EP3250139A4 - Thérapie électromagnétique pulsée et par ultrasons pour stimuler des protéines de choc thermique ciblées et faciliter une réparation de protéine - Google Patents

Thérapie électromagnétique pulsée et par ultrasons pour stimuler des protéines de choc thermique ciblées et faciliter une réparation de protéine Download PDF

Info

Publication number
EP3250139A4
EP3250139A4 EP15880628.1A EP15880628A EP3250139A4 EP 3250139 A4 EP3250139 A4 EP 3250139A4 EP 15880628 A EP15880628 A EP 15880628A EP 3250139 A4 EP3250139 A4 EP 3250139A4
Authority
EP
European Patent Office
Prior art keywords
heat shock
shock proteins
ultrasound therapy
targeted heat
facilitating protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP15880628.1A
Other languages
German (de)
English (en)
Other versions
EP3250139A1 (fr
Inventor
Jeffrey K. LUTTRULL
Benjamin W. L. Margolis
David B. Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ojai Retinal Technology LLC
Original Assignee
Ojai Retinal Technology LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/607,959 external-priority patent/US9168174B2/en
Priority claimed from US14/922,885 external-priority patent/US9427602B2/en
Application filed by Ojai Retinal Technology LLC filed Critical Ojai Retinal Technology LLC
Publication of EP3250139A1 publication Critical patent/EP3250139A1/fr
Publication of EP3250139A4 publication Critical patent/EP3250139A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0625—Warming the body, e.g. hyperthermia treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/067—Radiation therapy using light using laser light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B2018/2065—Multiwave; Wavelength mixing, e.g. using four or more wavelengths
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/063—Radiation therapy using light comprising light transmitting means, e.g. optical fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0642—Irradiating part of the body at a certain distance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0043—Ultrasound therapy intra-cavitary
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
EP15880628.1A 2015-01-28 2015-11-16 Thérapie électromagnétique pulsée et par ultrasons pour stimuler des protéines de choc thermique ciblées et faciliter une réparation de protéine Pending EP3250139A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14/607,959 US9168174B2 (en) 2012-05-25 2015-01-28 Process for restoring responsiveness to medication in tissue of living organisms
US201562153616P 2015-04-28 2015-04-28
US14/922,885 US9427602B2 (en) 2012-05-25 2015-10-26 Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair
PCT/US2015/060893 WO2016122752A1 (fr) 2015-01-28 2015-11-16 Thérapie électromagnétique pulsée et par ultrasons pour stimuler des protéines de choc thermique ciblées et faciliter une réparation de protéine

Publications (2)

Publication Number Publication Date
EP3250139A1 EP3250139A1 (fr) 2017-12-06
EP3250139A4 true EP3250139A4 (fr) 2018-06-27

Family

ID=56544130

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15880628.1A Pending EP3250139A4 (fr) 2015-01-28 2015-11-16 Thérapie électromagnétique pulsée et par ultrasons pour stimuler des protéines de choc thermique ciblées et faciliter une réparation de protéine

Country Status (8)

Country Link
EP (1) EP3250139A4 (fr)
JP (2) JP6480588B2 (fr)
CN (1) CN107205768B (fr)
AU (1) AU2015380411B2 (fr)
BR (1) BR112017016288A2 (fr)
CA (2) CA2972416C (fr)
SG (1) SG11201705677WA (fr)
WO (1) WO2016122752A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017308587A1 (en) * 2016-08-09 2019-01-17 Ojai Retinal Technology, Llc Process for providing protective therapy for biological tissues or fluids
WO2018203930A1 (fr) * 2017-05-01 2018-11-08 Ojai Retinal Technology, Llc Système et procédé de traitement de la myopie
CN111343936B (zh) * 2017-11-15 2024-03-22 奥哈伊视网膜技术有限责任公司 利用能量治疗生物组织的方法及系统
US20210077190A1 (en) * 2018-04-24 2021-03-18 Centre National De La Recherche Scientifique Generator and method for affecting biological tissue and cells using microwave-induced heat profiles
CN112494135A (zh) * 2020-11-20 2021-03-16 毕勇 一种支气管哮喘的激光热成形治疗装置

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023147A1 (fr) * 1998-10-20 2000-04-27 Dornier Medtech Holding International Gmbh Therapie thermique assortie d'une protection des tissus
WO2009088550A2 (fr) * 2007-10-19 2009-07-16 Lockheed Martin Corporation Système et procédé de conditionnement de tissu animal par rayon laser
US20140074191A1 (en) * 2012-09-10 2014-03-13 Dermal Photonics Corporation Systems and methods for usage replenishment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348002A (en) * 1992-04-23 1994-09-20 Sirraya, Inc. Method and apparatus for material analysis
JP2001104334A (ja) * 1999-10-08 2001-04-17 Olympus Optical Co Ltd 医療用システム
GB0422525D0 (en) * 2004-10-11 2004-11-10 Luebcke Peter Dermatological compositions and methods
JP2008109954A (ja) * 2006-10-27 2008-05-15 Matsushita Electric Works Ltd カプセル型撮像装置
US20100092424A1 (en) * 2007-11-21 2010-04-15 Sanghvi Narendra T Method of diagnosis and treatment of tumors using high intensity focused ultrasound
US8141557B2 (en) * 2008-10-22 2012-03-27 Peyman Gholam A Method of oscillatory thermotherapy of biological tissue
US10219947B2 (en) * 2012-05-25 2019-03-05 Ojai Retinal Technology, Llc System and process for retina phototherapy
US9333371B2 (en) * 2012-11-01 2016-05-10 Seminex Corporation Variable intensity laser treatments of the skin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023147A1 (fr) * 1998-10-20 2000-04-27 Dornier Medtech Holding International Gmbh Therapie thermique assortie d'une protection des tissus
WO2009088550A2 (fr) * 2007-10-19 2009-07-16 Lockheed Martin Corporation Système et procédé de conditionnement de tissu animal par rayon laser
US20140074191A1 (en) * 2012-09-10 2014-03-13 Dermal Photonics Corporation Systems and methods for usage replenishment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016122752A1 *

Also Published As

Publication number Publication date
AU2015380411B2 (en) 2019-03-14
SG11201705677WA (en) 2017-08-30
CN107205768B (zh) 2020-06-16
WO2016122752A1 (fr) 2016-08-04
JP6778772B2 (ja) 2020-11-04
CA3063889C (fr) 2023-03-14
EP3250139A1 (fr) 2017-12-06
JP2019108334A (ja) 2019-07-04
CA2972416C (fr) 2020-01-14
AU2015380411A1 (en) 2017-07-20
BR112017016288A2 (pt) 2018-03-27
CN107205768A (zh) 2017-09-26
CA3063889A1 (fr) 2016-08-04
JP2018503434A (ja) 2018-02-08
JP6480588B2 (ja) 2019-03-13
CA2972416A1 (fr) 2016-08-04

Similar Documents

Publication Publication Date Title
IL266222A (en) Messenger RNA acids for increasing immune responses and methods for their use
GB2604416B (en) Tumor infiltating lymphocytes and methods of therapy
IL252917A0 (en) Vectors and vectors for gene therapy for use in the treatment of Wilson's disease
EP3318579A4 (fr) Protéine de fusion à base d'interleukine 15 pour la thérapie de ciblage de tumeurs
EP3188799A4 (fr) Méthodes de traitement de troubles cutanés et du vieillissement à l'aide d'acides nucléiques ciblant tyr ou mmp1
EP3250139A4 (fr) Thérapie électromagnétique pulsée et par ultrasons pour stimuler des protéines de choc thermique ciblées et faciliter une réparation de protéine
ZA201804223B (en) Bromodomain and extra-terminal protein inhibitor combination therapy
PL3362145T3 (pl) Regulowany oświetlacz do terapii fotodynamicznej i diagnostyki
HK1258376A1 (zh) 用於組織修復的雙特異性治療性蛋白質
PL3242947T3 (pl) Terapia genowa i elektroporacja do leczenia zmian złośliwych
IL256000A (en) Quantifying her 2 protein for optimal cancer therapy
LT3532059T (lt) Bromodomeno ir papildomo galinio baltymo inhibitorių derinio terapija
IL270746A (en) Inducers of heat shock proteins and frontal disorders
ZA201904736B (en) Targeted doxorubicin-gold nanoconjugates for tumor therapy
IL271327A (en) Compositions and methods for enhancing hyperthermic therapy
ZA201902689B (en) Therapeutic protein
HK1251512A1 (zh) 靶向蛋白造影劑、其製備方法及用途
EP3283528A4 (fr) Anticorps humain anti-vegfr2 pour traitement anti-angiogénique et anticancéreux ciblé
ZA202000152B (en) Means and methods for aav gene therapy in humans
HK1257223A1 (zh) 一種中和促細胞程序性壞死抗體的蛋白及其應用
EP3476436A4 (fr) Dispositif de thérapie ultrasonore utilisant hifu.
GB201616715D0 (en) Therapeutic protein
GB201602192D0 (en) Therapeutic and diagnostic target

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20170714

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20180528

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 18/20 20060101ALI20180522BHEP

Ipc: A61B 18/04 20060101AFI20180522BHEP

Ipc: A61N 2/02 20060101ALI20180522BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20190129

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS